selected publications
- Comparison of Cancer Registry Data Between Sweden and China and the Impact on Real-World Health Research. Value in health regional issues. 2025 Academic Article GET IT
- A population-based recalibration method for updating survival neural networks models for cardiovascular risk prediction in United Kingdom and China. Journal of clinical epidemiology. 2025 Academic Article GET IT
-
Barriers and facilitators to implementing imaging-based diagnostic artificial intelligence-assisted decision-making software in hospitals in China: a qualitative study using the updated Consolidated Framework for Implementation Research.
BMJ open.
2024
Academic Article
GET IT
Times cited: 13 -
Key Issues of Economic Evaluations for Health Technology Assessment in China: A Nationwide Expert Survey.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
2024
Academic Article
GET IT
Times cited: 4 -
Changing inequity in health service utilization and financial burden among patients with hypertension in China: evidence from China Health and Retirement Longitudinal Study (CHARLS), 2011-2018.
International journal for equity in health.
2023
Academic Article
GET IT
Times cited: 8 -
Recent advancement in integrating artificial intelligence and information technology with real-world data for clinical decision-making in China: A scoping review.
Journal of evidence-based medicine.
2023
Academic Article
GET IT
Times cited: 8 -
Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan.
International journal of general medicine.
2016
Academic Article
GET IT
Times cited: 9 -
Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.
BMC health services research.
2016
Academic Article
GET IT
Times cited: 104 -
Pharmacologic Prophylaxis for Venous Thromboembolism Among Patients With Total Joint Replacement: An Electronic Medical Records Study.
American journal of therapeutics.
2016
Academic Article
GET IT
Times cited: 3 -
Pharmacological Prophylaxis for Venous Thromboembolism Among Hospitalized Patients With Acute Medical Illness: An Electronic Medical Records Study.
American journal of therapeutics.
2016
Academic Article
GET IT
Times cited: 3 -
Impact of Out-of-Pocket Costs on Prescription Fills Among New Initiators of Biologic Therapies for Rheumatoid Arthritis.
Journal of managed care & specialty pharmacy.
2015
Academic Article
GET IT
Times cited: 36 -
Cost-effectiveness Analysis of Apixaban against Warfarin for Stroke Prevention in Patients with Nonvalvular Atrial Fibrillation in Japan.
Clinical therapeutics.
2015
Academic Article
GET IT
Times cited: 9 -
Improving diabetes medication adherence: successful, scalable interventions.
Patient preference and adherence.
2015
Information Resource
GET IT
Times cited: 65 -
A review of the pharmacoeconomics of eletriptan for the acute treatment of migraine.
International journal of general medicine.
2015
Information Resource
GET IT
Times cited: 7 -
Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.
European heart journal.
2014
Academic Article
GET IT
Times cited: 78 -
Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation.
Clinical therapeutics.
2014
Academic Article
GET IT
Times cited: 53 -
Smoky coal, tobacco smoking, and lung cancer risk in Xuanwei, China.
Lung cancer (Amsterdam, Netherlands).
2014
Academic Article
GET IT
Times cited: 55 -
Treatment patterns associated with stroke prevention in patients with atrial fibrillation in three major cities in the People's Republic of china.
International journal of general medicine.
2013
Academic Article
GET IT
Times cited: 3 -
Cost of venous thromboembolism in hospitalized medically ill patients.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
2013
Academic Article
GET IT
Times cited: 11 -
Impact of an integrated intervention program on atorvastatin adherence: a randomized controlled trial.
International journal of general medicine.
2013
Academic Article
GET IT
Times cited: 11 -
History of lung disease and risk of lung cancer in a population with high household fuel combustion exposures in rural China.
Lung cancer (Amsterdam, Netherlands).
2013
Academic Article
GET IT
Times cited: 27 -
Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
Circulation. Cardiovascular quality and outcomes.
2013
Academic Article
GET IT
Times cited: 7 -
The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment.
Health affairs (Project Hope).
2012
Academic Article
GET IT
Times cited: 51 -
Coal mining is associated with lung cancer risk in Xuanwei, China.
American journal of industrial medicine.
2011
Academic Article
GET IT
Times cited: 35 -
Determining initial and follow-up costs of cardiovascular events in a US managed care population.
BMC cardiovascular disorders.
2011
Academic Article
GET IT
Times cited: 28 -
A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in hypertensive patients without prior cardiovascular disease.
American journal of therapeutics.
2011
Academic Article
GET IT
Times cited: 2 -
The utility of observational studies in clinical decision making: lessons learned from statin trials.
Postgraduate medicine.
2010
Academic Article
GET IT
Times cited: 5 -
Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol.
American journal of therapeutics.
2010
Academic Article
GET IT
Times cited: 21 -
Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.
Cardiovascular diabetology.
2009
Academic Article
GET IT
Times cited: 43 -
Generic and therapeutic statin switches and disruptions in therapy.
Current medical research and opinion.
2009
Academic Article
GET IT
Times cited: 18 -
Variation in lung cancer risk by smoky coal subtype in Xuanwei, China.
International journal of cancer.
2008
Academic Article
GET IT
Times cited: 94 -
A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease.
Diabetes research and clinical practice.
2008
Academic Article
GET IT
Times cited: 1 -
Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study.
Current medical research and opinion.
2008
Academic Article
GET IT
Times cited: 40 -
Dietary factors, food contamination and lung cancer risk in Xuanwei, China.
Lung cancer (Amsterdam, Netherlands).
2008
Academic Article
GET IT
Times cited: 36 -
An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes.
PharmacoEconomics.
2008
Academic Article
GET IT
Times cited: 28 -
Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States.
Clinical therapeutics.
2008
Academic Article
GET IT
Times cited: 36 -
Economic impacts attributable to the early clinical benefit of atorvastatin therapy--a US managed care perspective.
Current medical research and opinion.
2007
Academic Article
GET IT
Times cited: 10 -
Therapeutic dose assessment of patient switching from atorvastatin to simvastatin.
The American journal of managed care.
2007
Academic Article
GET IT
Times cited: 25 -
A comparison of costs and hospital length of stay associated with intravenous/oral linezolid or intravenous vancomycin treatment of complicated skin and soft-tissue infections caused by suspected or confirmed methicillin-resistant Staphylococcus aureus in elderly US patients.
Clinical therapeutics.
2007
Academic Article
GET IT
Times cited: 37 -
The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective.
Managed care interface.
2007
Academic Article
GET IT
Times cited: 18 -
Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Clinical therapeutics.
2006
Academic Article
GET IT
Times cited: 40